Increased coping motives during the COVID-19 pandemic widen cannabis disparities between sexual minoritized and nonminoritized young adults: A bimonthly assessment of data preceding and spanning the pandemic.
Psychology of Addictive Behaviors · 2023
DOI: 10.1037/adb0000939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychology of Addictive Behaviors, 2023. Verfasst von Connor J McCabe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Center for the Study of Health and Risk Behaviors, University of Washington. Hauptthemen laut MEDLINE: Cannabis, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
OBJECTIVE: Since the start of the coronavirus pandemic, some U.S. adults have increased alcohol and cannabis use frequency to cope with distress. Among sexual minoritized young adults (SM YAs), coping-related use may be greater due to disproportionate negative social and financial consequences of the pandemic. Nonetheless, it remains unclear whether pandemic substance use has increased among SM YAs compared to non-SM YAs relative to prepandemic levels and whether heightened coping motives mediate these potential differences. METHOD: A total of 563 YAs (18-24 years at baseline; 31.0% SM) provided survey data collected across 12 bimonthly assessments. Six assessments were measured in 2015 or 2016 and six across the coronavirus pandemic (2020-2021). Controlling for prepandemic assessments matched by calendar month, latent structural equation models examined group differences in alcohol and cannabis frequency and consequences across the COVID-19 period and tested coping motives as mediators of these differences. RESULTS: Substance use and consequences were similar during the pandemic relative to prepandemic levels across groups. Nonetheless, compared to non-SM individuals, SM participants reported greater cannabis frequency, consequences, and cannabis coping motives during the pandemic independent of prepandemic levels. Cannabis use and consequences were each explained largely by coping motives during the pandemic among SM compared to non-SM YAs. These patterns were not found for alcohol outcomes. CONCLUSIONS: The COVID-19 pandemic has widened cannabis disparities between SM and non-SM YAs, due in part to pandemic-related increases in coping motives. Responsive public policy is needed that may prevent and remit SM cannabis disparities during societal crises. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, Center for the Study of Health and Risk Behaviors, University of Washington.
ORCID-Profile: Connor J McCabe
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
McCabe, C. J., Rhew, I. C., Walukevich-Dienst, K., Graupensperger, S., & Lee, C. M. (2023). Increased coping motives during the COVID-19 pandemic widen cannabis disparities between sexual minoritized and nonminoritized young adults: A bimonthly assessment of data preceding and spanning the pandemic. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000939
Vancouver
McCabe CJ, Rhew IC, Walukevich-Dienst K, Graupensperger S, Lee CM. Increased coping motives during the COVID-19 pandemic widen cannabis disparities between sexual minoritized and nonminoritized young adults: A bimonthly assessment of data preceding and spanning the pandemic. Psychology of Addictive Behaviors. 2023. doi:10.1037/adb0000939
BibTeX
@article{McCabe2023,
author = {McCabe, Connor J and Rhew, Isaac C and Walukevich-Dienst, Katherine and Graupensperger, Scott and Lee, Christine M},
title = {Increased coping motives during the COVID-19 pandemic widen cannabis disparities between sexual minoritized and nonminoritized young adults: A bimonthly assessment of data preceding and spanning the pandemic},
journal = {Psychology of Addictive Behaviors},
year = {2023},
doi = {10.1037/adb0000939}
}
EUVIMED